Penjelasan Cara Penggunaan Inhaler Ipratropium Bromida oleh Apoteker
DOI:
Abstract Views:
599 times
PDF Downloads:
521 times
Abstract
Abstract—MDI (metered-dose inhaler) containing Ipratropium Bromide is used to control COPD symptoms. Improper use can trigger unwanted effects, so it takes the role of pharmacists in helping explain how to use it. The purpose of this study was to determine the completeness of the explanation by pharmacists in pharmacies regarding how to use MDI containing ipratropium bromide. This research method is cross-sectional with purposive sampling, using an observation technique in the form of a checklist. The sample in this study were pharmacists at pharmacies in East Surabaya. The data obtained will be processed by descriptive analysis. The research sample was 22 pharmacists. The results showed that all pharmacists were able to explain the steps for opening and closing the inhaler. In addition, the steps for holding the inhaler (21 pharmacists), the sub-step closing with the lips (20 pharmacists), the step of placing the mouthpiece between the teeth and breathing (18 pharmacists), the step of cleaning the mouthpiece (15 pharmacists), the step of exhaling slowly (14 pharmacists), the breath holding step (13 pharmacists), the exhaling step during preparation (12 pharmacists), the sub-step putting the tongue under the mouthpiece and the slow inhalation step (11 pharmacists). However, there is no pharmacist who is able to explain the steps to take if not used for 3 days and the use that must be careful of the eyes. Therefore, the ability of pharmacists to explain how to use MDI containing Ipratropium Bromide should be improved.
Keywords: information on how to use Metered-Dose Inhaler (MDI), Ipratropium Bromide, pharmacist, pharmacy
Abstrak—MDI (metered-dose inhaler) yang mengandung Ipratropium Bromida digunakan untuk mengontrol gejala PPOK. Penggunaan yang tidak tepat dapat memicu efek yang tidak diinginkan, sehingga dibutuhkan peran apoteker dalam membantu menjelaskan cara penggunaannya. Tujuan penelitian ini adalah mengetahui kelengkapan penjelasan oleh apoteker di apotek terkait cara penggunaan MDI yang mengandung ipratropium bromida. Metode penelitian ini adalah cross-sectional dengan purpossive sampling, menggunakan teknik observasi berupa checklist. Sampel dalam penelitian adalah apoteker di apotek di Surabaya Timur. Data yang diperoleh akan diolah dengan analisis deskriptif. Sampel penelitian sebanyak 22 apoteker. Hasil penelitian menunjukkan semua apoteker mampu menjelaskan langkah membuka dan menutup inhaler. Selain itu langkah posisi memegang inhaler (21 apoteker), sub langkah menutup dengan bibir (20 apoteker), langkah meletakkan mouthpiece diantara gigi dan bernapas (18 apoteker), langkah membersihkan mouthpiece (15 apoteker), langkah menghembuskan napas perlahan (14 apoteker), langkah menahan napas (13 apoteker), langkah menghembuskan napas saat persiapan (12 apoteker), sub langkah meletakkan lidah dibawah mouthpiece dan langkah tarik napas perlahan (11 apoteker). Namun tidak ada apoteker yang mampu menjelaskan langkah yang dilakukan jika tidak digunakan selama 3 hari dan penggunaan yang harus berhati-hati terhadap mata. Oleh karena itu, kemampuan apoteker dalam menjelaskan cara penggunaan MDI yang mengandung Ipratropium Bromida harus ditingkatkan.
Kata kunci: informasi cara penggunaan Metered-Dose Inhaler (MDI), Ipratropium Bromida, apoteker, apotek
Downloads
References
Global Initiative for Chronic Obstructive Lung Disease, 2017, Global Strategy for The Diagnosis,Management, And Prevention of Chronic Obstructive Pulmonary Disease, GOLD, updated 2014, (online),(http://www.goldcopd.org diakses 21 Januari 2018)
Dennis, William dan Sharya V. Bourdet in Dipiro JT et al, 2008, Pharmacotherapy A Pathophisiologic Approach, 7th edition, The McGraw Hill Companies, United States of America, Chapter 29, 495-518
Ikawati Z, 2009. Farmakoterapi Penyakit Sistem Pernafasan. Penerbit Pustaka Adipura, Yogyakarta, Indonesia.
Oemiati R. 2013. Kajian Epidemiologis Penyakit Paru Obstruktif Kronis (PPOK). Medi Litbangkes. 23(2):82-88.
Appleton et al,2007, Ipratropium Bromide Versus Short Acting Beta-2 Agonists for Stable Chronic Obstructive Pulmonary Disease. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD001387. DOI: 10.1002/14651858.CD001387.pub2,129-33.
Newman SP, 2005, Inhaler Treatment Options in COPD, Eur Respir Rev 14 (96): 102–108.
Terzano C, 2011, Pressurized Metered Dose Inhalers and Add-on Devices, Department of Cardiovascular and Respiratory Sciences, University La Sapienza, Rome, Italy.
Keputusan Menteri Kesehatan Republik Indonesia Nomor 1027/MENKES/SK/IX/2004 tentang Standar Pelayanan Kefarmasian di Apotek, 2004, Jakarta.
Hämmerlein A, Muller U, Schulz M, Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients. Journal of Evaluation in Clinical Practice. 2010;1-10.
Onda M, Sakurai H, Hayase Y, Sakamaki H, Arakawa Y, Yasukawa F. Effects of Patient-Pharmacist Communication on the Treatment of Asthma, Yakugaku Zasshi, 2009;129(4):427-433.
Nadi E & Zeraati F. Evaluation of The Metered-Dose Inhaler Technique Among Healthcare Providers. Department of Internal Medicine, Mobasher Kashani Hospital, School of Medicine. Hamedan University of Medical Sciences, Hamedan, Iran. 2005;268-272.
Lalani NS, A study of knowledge assessment and competence in asthma and inhaler technique of nurses employed at university teaching hospital. TheHealth. 2012; 3(1): 16-18.
Lorensia A, Queljoe DD, Santosa KA. 2015. Kelengkapan Informasi Mengenai Cara Penggunaan Peak Flow Meter yang Diberikan kepada Pasien Asma di Apotek. Jurnal Ilmiah Manuntung (JIM) Sains Farmasi dan Kesehatan, Akademi Farmasi Samarinda, December 2015, Vol. 1, No. 2, p8-18. (ISSN:2443-115X)
Lorensia A, Queljoe DD, Santoso ZD, Setiawan H. 2015. Completeness of Information of Metered Dose Inhaler (MDI) Use in Asthma Patients in Pharmacies [Oral Presentation]. The 4th International Conference on Pharmacy and Advanced Pharmaceutical Sciences: Integrating Sosio-enterpreneurship in Marine Development for Sustainable Pharmacy. Organized by Gadjah Mada University, Indonesia, in cooperation with Universiti Sains Malaysia, Malaysia, and Nara Institute of Science and Technology (NAIST) Jepang. In Sheraton Mustika Hotel Resort & Spa Yogyakarta, Yogyakarta. 7-8 September 2015.
Lorensia A, Queljoe DD, Karina BL, Hewu A. 2016. Studi Kelengkapan Penjelasan Cara Penggunaan Sediaan Controller Inhaler (Kombinasi Kortikosteroid Dengan Beta-2 Agonis) Jenis Diskus® Dan Turbuhaler® Oleh Apoteker Di Apotek. Jurnal Ilmiah Manuntung (JIM) Sains Farmasi dan Kesehatan, Akademi Farmasi Samarinda. Desember 2016; 2(2):137-146. (ISSN CETAK. 2443-115X dan ISSN ELEKTRONIK. 2477-1821).
Osman A, Hassan ISA, Ibrahim MIM. Are Sudanese community pharmacists capable to prescribe and demonstrate asthma inhaler devices to patrons? A mystery patient study. Pharmacy Practice (Internet), 2012;10(2):110-115
Beaucage D, Nesbittt S. Using Inhalation Device, in Bourbeau, Nault, Borycki, Comprehensive Management of Chronic Obstructive Pulmonary Disease, BC Decker Inc., Canada, p.83-107; 2002
The American College of Chest Physician, 2006, Using Your MDI Closed Mouth Technique-Patient education Guide, Northbrook, (online) (http://www. Chest net.org diakses 11 mei 2014)
Francis C., 2006. Perawatan Respirasi. Penerbit Erlangga, Jakarta, Indonesia: 22-58
National Asthma Council Australia, 2008, Inhaler Technique in Adults with Asthma or COPD
Terzano C, 2011, Pressurized Metered Dose Inhalers and Add-on Devices, Department of Cardiovascular and Respiratory Sciences, University La Sapienza, Rome, Italy.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Articles published in Keluwih: JKK are licensed under a Creative Commons Attribution-ShareAlike 4.0 International license. You are free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided you give appropriate credit to the original author(s) and the journal, link to the license, indicate if changes were made, and redistribute any derivative work under the same license.
- Copyright on articles is retained by the respective author(s), without restrictions. A non-exclusive license is granted to Kluwih: JKK to publish the article and identify itself as its original publisher, along with the commercial right to include the article in a hardcopy issue for sale to libraries and individuals.
- By publishing in Keluwih: JKK, authors grant any third party the right to use their article to the extent provided by the Creative Commons Attribution-ShareAlike 4.0 International license.
